Navigation Links
Chiltern is Designed Around You

LONDON and WILMINGTON, N.C., Nov. 3, 2014 /PRNewswire/ -- With a renewed therapeutic specialization, deepened service offering and expanded geographic footprint, Chiltern launches today as a completely integrated and unified CRO with services that are "Designed Around You".

"We hear from our clients that Chiltern listens first in order to adapt to each unique relationship," said Chiltern CEO, Dr Jim Esinhart. "Our refreshed theme is a direct response, as we steadily grow to meet the needs of our customers. Chiltern's culture embraces creativity and deep engagement through the application of therapeutic expertise within a flexible global platform that is distinctly 'Designed Around You.'"

The new Chiltern provides multinational therapeutic specialization in respiratory, anti-infectives / vaccines, ophthalmology and dermatology. In addition, the Chiltern Oncology division uniquely manages all phases of clinical development in a complex, constantly evolving cancer research environment. And the Chiltern Source division provides tailored relationships for FSP, resourcing and staffing at a functional level for clinical, biometrics, medical and regulatory needs.

Chiltern will be on display at the 13th Annual Partnerships in Clinical Trials Congress, 5th-6th November in Barcelona and the 56th Annual American Society of Hematology (ASH) Meeting and Exposition, 6th-9th December in San Francisco. Meeting requests are welcome via

Further, Chiltern is pleased to make available its new e-book, Oncology Research Today, highlighting current developments in cancer research. This volume of five white papers can be viewed at A limited number of hardcopies will be available by visiting Chiltern booth #541 during the ASH conference.

About Chiltern:
Chiltern is a leading CRO that listens to client needs in order to customize solutions for the Biopharma industry. With a 32 year history, Chiltern delivers globally with therapeutic expertise in oncology, respiratory, anti-infectives / vaccines, ophthalmology and dermatology. Chiltern operates two specialty units: Chiltern Oncology is led by physicians, scientists and clinicians to uniquely manage all phases of hematologic and oncologic clinical drug development; and Chiltern Source is a world leader in tailored relationships for FSP, resourcing and staffing solutions. Chiltern's 2,200 engaged professionals work across 45 countries to deliver flexible, responsive solutions that are "Designed Around You".

Further information is available at:

For more information contact: 
Nicholas Spittal 
Sr. Director, Global Commercial Affairs 
Chiltern International Inc.
4000 Centregreen Way, Suite 300
Cary, NC 27513
Tel: +1 (919) 462 8867 

SOURCE Chiltern
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Chiltern acquires Pacific Clinical Research Pte Limited and expands operations and therapeutic depth in Asia-Pacific
2. Chiltern acquires Ockham and the companies merge operations
3. Chiltern Announces The Consolidation Of Existing Investor Base
4. Auxilium Pharmaceuticals, Inc. Announces Corporate Restructuring Designed To Streamline Operations, Maximize Cash Flow And Drive Sustainable Earnings Growth
5. ITC Rules Redesigned APEX Humidifier Still Infringes ResMed Patents
6. ViaCyte Files Investigational New Drug Application and Device Master File with FDA for Novel Cell Replacement Therapy Product Candidate Designed to Treat Patients with Type 1 Diabetes
7. EMD Seronos Redesigned Fertility Pen Available for Distribution in US
8. Varian Medical Systems Exhibits New Flat-Panel Digital X-ray Image Detectors Designed for High Energy Industrial and Security Applications
9. New Syringe Designed to Position More Large Volume Injectable Drugs for Prefill Administration
10. Lexicon Presents Preclinical Data On LX2761, a New Clinical Candidate for Diabetes Designed to Reduce Glucose Absorption From Gastrointestinal Tract
11. Upsher-Smith Introduces Newly Redesigned Corporate Website
Post Your Comments:
(Date:6/24/2020)... ... ... The Safe Boating Campaign, a worldwide effort focused on responsible boating, reminds boaters ... the leading contributing factor in recreational boater deaths, according to the U.S. Coast Guard. ... for drinking and boating, and deadly accidents,” said Peg Phillips, executive director of the ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... the "Company"), a leading provider of center-based, Applied Behavioral Analysis ("ABA") therapy, ... center-based ABA provider in the greater-Indianapolis market. This acquisition will make Lighthouse ...
(Date:6/19/2020)... ... June 19, 2020 , ... The Covid-19 pandemic has had an undeniable impact ... environment and compliant workforce is critical in the post-Covid world. , To help our ... vending machine below cost for a limited time only. , “We are literally ...
Breaking Medicine Technology:
(Date:7/2/2020)... ... July 02, 2020 , ... The Coronavirus (COVID-19) pandemic resulted ... In conjunction with the American Dental Association and Centers for Disease Control and ... , Due to safety concerns, the announcement sparked hesitancy among some hygienists, who ...
(Date:7/1/2020)... ... July 01, 2020 , ... ABSTRAX, an industry leader in ... new terpene infused product line including custom rolling papers, cones, flat wraps, ... profiles and flavors worldwide. , “We’ve made it easier than ever for brands ...
(Date:7/1/2020)... EVANSTON, Ill. (PRWEB) , ... July 01, 2020 ... ... today announced that Doug Salvador, MD, Associate Professor of Medicine at the University ... Healthcare Risk and Safety Strategies, LLC have joined the SIDM Board of Directors. ...
(Date:6/28/2020)... ... June 26, 2020 , ... The Pool & Hot ... redesignation of the ANSI/APSP/ICC-7 2013 American National Standard for Suction Entrapment Avoidance In ... member participation on the PHTA-7 Standard Writing Committee (SWC) for Suction Entrapment Avoidance ...
(Date:6/28/2020)... ... June 26, 2020 , ... PathAI, a global provider of artificial intelligence ... analysis of digital scoring of PD-L1 expression to assess response in patients treated with ... 2020 American Association for Cancer Research (AACR) Annual Meeting. AACR was held June 22 ...
Breaking Medicine News(10 mins):